title: Topical bioavailability of triamcinolone acetonide: effect of dose and application frequency.
abstract: The application frequency of topical corticosteroids is a recurrently debated topic. Multiple-daily applications are common, although a superior efficacy compared to once-daily application is not unequivocally proven. Only few pharmacokinetic studies investigating application frequency exist. The aim of the study was to investigate the effect of dose (Experiment 1) and application frequency (Experiment 2) on the penetration of triamcinolone acetonide (TACA) into human stratum corneum (SC) in vivo. The experiments were conducted on the forearms of 15 healthy volunteers. In Experiment 1, single TACA doses (300 microg/cm(2) and 100 microg/cm(2)) dissolved in acetone were applied on three sites per arm. In experiment 2, single (1 x 300 microg/cm(2)) and multiple (3 x 100 microg/cm(2)) TACA doses were similarly applied. SC samples were harvested by tape stripping after 0.5, 4 and 24 h (Experiment 1) and after 4, 8 and 24 h (Experiment 2). Corneocytes and TACA were quantified by UV/VIS spectroscopy and HPLC, respectively. TACA amounts penetrated into SC were statistically evaluated by a paired-sample t-test. In Experiment 1, TACA amounts within SC after application of 1 x 300 microg/cm(2) compared to 1 x 100 microg/cm(2) were only significantly different directly after application and similar at 4 and 24 h. In Experiment 2, multiple applications of 3 x 100 microg/cm(2) yielded higher TACA amounts compared to a single application of 1 x 300 microg/cm(2) at 4 and 8 h. At 24 h, no difference was observed. In conclusion, using this simple vehicle, considerable TACA amounts were retained within SC independently of dose and application frequency. A low TACA dose applied once should be preferred to a high dose, which may promote higher systemic exposure.
authors.affiliation: Hospital Pharmacy, University Hospital Basel, Spitalstrasse 26, 4031, Basel, Switzerland.
authors.forename: Carolina
authors.initials: C
authors.lastname: Pellanda
authors.forename: Evelyne
authors.initials: E
authors.lastname: Ottiker
authors.forename: Christoph
authors.initials: C
authors.lastname: Strub
authors.forename: Verena
authors.initials: V
authors.lastname: Figueiredo
authors.forename: Theo
authors.initials: T
authors.lastname: Rufli
authors.forename: Georgios
authors.initials: G
authors.lastname: Imanidis
authors.forename: Christian
authors.initials: C
authors.lastname: Surber
mesh_terms: D000269:Adhesives; D000287:Administration, Topical; D000328:Adult; D004817:Epidermis / Q000378:metabolism*; D005260:Female; D005938:Glucocorticoids / Q000008:administration & dosage* / Q000493:pharmacokinetics*; D006801:Humans; D008297:Male; D014222:Triamcinolone Acetonide / Q000008:administration & dosage* / Q000493:pharmacokinetics*
chemical_list: D000269:Adhesives; D005938:Glucocorticoids; D014222:Triamcinolone Acetonide